首页> 外文期刊>Allergy >Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited
【24h】

Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited

机译:哮喘,过敏性鼻炎和慢性鼻窦炎的上下呼吸道重塑机制:一个呼吸道概念重新审视

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Allergic rhinitis ( AR ), chronic rhinosinusitis ( CRS ) and asthma often co‐exist. The one airway model proposes that disease mechanisms occurring in the upper airway may mirror lower airway events. Airway remodelling is the term used to describe tissue structural changes that occur in a disease setting and reflect the dynamic process of tissue restructuring during wound repair. Remodelling has been long identified in the lower airways in asthma and is characterized by epithelial shedding, goblet cell hyperplasia, basement membrane thickening, subepithelial fibrosis, airway smooth muscle hyperplasia and increased angiogenesis. The concept of upper airway remodelling has only recently been introduced, and data so far are limited and often conflicting, an indication that more detailed studies are needed. Whilst remodelling changes in AR are limited, CRS phenotypes demonstrate epithelial hyperplasia, increased matrix deposition and degradation along with accumulation of plasma proteins. Despite extensive research over the past years, the precise cellular and molecular mechanisms involved in airway remodelling remain incompletely defined. This review describes our current rather limited understanding of airway remodelling processes in AR , CRS and asthma and presents mechanisms both shared and distinct between the upper and lower airways. Delineation of shared and disease‐specific pathogenic mechanisms of remodelling between the sinonasal system and the lung may guide the rational design of more effective therapeutic strategies targeting upper and lower airways concomitantly and improving the health of individuals with inflammatory airway diseases.
机译:摘要过敏性鼻炎(AR),慢性鼻窦炎(CRS)和哮喘通常共存。一款气道模型提出,上呼吸道中发生的疾病机制可能会镜像下呼吸道事件。气道重塑是用于描述疾病环境中发生的组织结构变化的术语,并反映伤口修复过程中组织重组的动态过程。重塑已经在哮喘下的较低气道中识别,其特征在于上皮脱落,脚石细胞增生,基底膜增稠,耻骨纤维化,气道平滑肌增生和增加的血管生成。最近才介绍上呼吸道重塑的概念,迄今为止的数据是有限的,通常是矛盾的,这是需要更详细的研究的指示。在AR的重塑变化的情况下,CRS表型示出了上皮增生,增加了基质沉积和降解以及血浆蛋白的积累。尽管过去几年进行了广泛的研究,但涉及呼吸道重塑的精确细胞和分子机制仍然不完全定义。本综述描述了我们目前的相当有限地了解AR,CRS和哮喘中的气道重塑过程,并在上下航向和下航向之间呈现共享和不同的机制。描绘了Sinonasal系统和肺部之间的共用和疾病特异性致病机制,可以指导统计上下呼吸道的更有效的治疗策略的合理设计,并改善炎症气道疾病的个体健康。

著录项

  • 来源
    《Allergy》 |2018年第5期|共10页
  • 作者单位

    Cellular Immunology LaboratoryBiomedical Research Foundation of the Academy of Athens (BRFAA)Athens;

    Department of Allergy Clinical Immunology and Medical RhinologyRoyal National Throat Nose Ear;

    Department of Allergy Clinical Immunology and Medical RhinologyRoyal National Throat Nose Ear;

    Cellular Immunology LaboratoryBiomedical Research Foundation of the Academy of Athens (BRFAA)Athens;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

    airway; asthma; remodelling; rhinitis; rhinosinusitis;

    机译:气道;哮喘;重塑;鼻炎;鼻炎;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号